Genotoxicity of cis-Pt(II) complex of 3-aminoflavone in comparison with cis-DDP in A549 cells evaluated by comet assay

Canadian Journal of Physiology and Pharmacology

Volumn 82, Issue 5, 2004, Pages 353-358

  Kosmider, Beata ^a   Zyner, Elzbieta ^b   Osiecka, Regina ^a   Ochocki, Justyn ^b  

^a UNIVERSITY OF LODZ   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

A549 cells; cis DDP; cis Pt(II) complex of 3 aminoflavone; Comet assay

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CISPLATIN DERIVATIVE; FLAVONE DERIVATIVE; HYDROGEN PEROXIDE; PLATINUM COMPLEX; 3 AMINOFLAVONE; 3-AMINOFLAVONE; DRUG DERIVATIVE; FLAVONOID;

ARTICLE; CANCER CHEMOTHERAPY; CELL LINE; COMET ASSAY; COMPARATIVE STUDY; CROSS LINKING; DNA CROSS LINKING; DNA DAMAGE; DNA DEGRADATION; DNA STRAND BREAKAGE; DRUG SCREENING; GENETIC VARIABILITY; GENOTOXICITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIDE EFFECT; CHEMISTRY; DOSE RESPONSE; METHODOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; CISPLATIN; COMET ASSAY; DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVONOIDS; HUMANS;

EID: 4143061491     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y04-021     Document Type: Article

References (22)

1. Ashby, J., Tinwell, H., Lefevre, P.A., and Browne, M.A. 1995. The single cell gel electrophoresis assay for induced DNA damage (comet assay): measurement of tail length and moment. Mutagenesis, 10: 85-90.
2. Blasiak, J., and Kowalik, J. 2001. Protective action of vitamin C against DNA damage induced by selenium-cisplatin conjugate. Acta Biochim. Pol. 48: 233-240.
3. Blasiak, J., Kowalik, J., Małecka-Panas, E., Drzewoski, J., and Wojewódzka, M. 2000. DNA damage and repair in human lymphocytes exposed to three anticancer platinum drugs. Teratog. Carcinog. Mutagen. 20: 119-131.
4. Ciesielska, E., Studzian, K., Zyner, E., Ochocki, J., and Szmigiero, L. 2000. DNA damage and apoptosis induction in L1210 cells by cis- diamminedichloroplatinum (II) and its new aminoflavone analogue. Cell. Mol. Biol. Lett. 5: 441-450.
5. Dancey, J., and Le Chevalier, T. 1997. Non-small cell lung cancer: an overview of current management. Eur. J. Cancer 33: S2-S7.
6. Ferguson, L.R., and Pearson, A.E. 1996. The clinical use of mutagenic anticancer drugs, Mutat. Res. 355: 1-12.
7. Hartmann, A., Kiskinis, E., Fjällman, A., and Suter, W. 2001. Influence of cytotoxicity and compound precipitation on test results in the alkaline comet assay. Mutat. Res. 497: 199-212.
8. Helma, C., and Uhl, M. 2000. A public domain image-analysis program for the single-cell gel-electrophoresis (comet) assay. Mutat. Res. 466: 9-15.
9. Jakupec, M.A., Galanski, M., and Keppler, B.K. 2003. Tumour-inhibiting platinum complexes state of the art and future perspectives. Rev. Physiol. Biochem. Pharmacol. 146: 1-53.
10. Kassie, F., Parzefall, W., Knasmüller, S. 2000. Single cell gel electrophoresis assay:a new technique for human biomonitoring studies. Mutat. Res. 463: 13-31.
11. Kosmider, B., Wyszynska, K., Janik-Spiechowicz, E., Osiecka, R., Zyner, E., Ochocki, J., Ciesielska, E., et al. 2004a. Genotoxicity evaluation of cis-Pt(II) complex of 3-aminoflavone in comparison with cis-DDP. Mutat. Res. 558: 93-110.
12. Kosmider, B., Osiecka, R., Ciesielska, E., Szmigiero, L., Zyner, E., and Ochocki, J. 2004b. Induction of apoptosis and necrosis in lymphocytes by the cis-Pt(II) complex of 3-aminoflavone in comparison with cis-DDP. Mutat. Res. 558: 169-179.
13. Merk, O., and Speit, G. 1999. Detection of crosslinks with the comet assay in relationship to genotoxicity and cytotoxicity, Environ. Mol. Mutagen. 33: 167-172.
14. O'Dwyer, P.J., Stevenson, J.P., and Johnson, S.W. 1999. Clinical status of cisplatin, carboplatin, and other platinum-based antitumor drugs. In Cisplatin: chemistry and biochemistry of a leading anticancer drug. Edited by B. Lippert. Verlag Helvetica Chimica Acta, Weinheim, New York, Wiley-VCH, Zürich, pp. 31-72.
15. Olive, P.L., Banáth, J.P., and Durand, R.E. 1990. Heterogeneity in radiation-induced DNA damage and repair in tumor and normal cells measured using the "comet" assay, Radiat. Res. 122: 86-94.
16. Reedijk, J. 1999. Why Does Cisplatin Reach Guanine-N7 with Competing S-Donor Ligands Available in the Cell? Chem. Rev. 99: 2499-2510.
17. Singh, N.P., McCoy, M.T., Tice, R.R., and Schneider, E.L. 1988. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 175: 184-191.
18. Spanswick, V.J., Hartley, J.M., Ward, T.H., and Hartley, J.A. 1999. Measurement of drug-induced DNA interstrand crosslinking using the single-cell gel electrophoresis (comet) assay. In Methods in Molecular Medicine, Vol. 28: Cytotoxic Drug Resistance Mechanisms Edited by R. Brown and U. Böger-Brown. Humana Press Inc., Totowa, NJ. pp. 143-154.
19. Storer, R.D., McKelvey, T.W., Kraynak, A.R., Elia, M.C., Barnum, J.E., Harmon, L.S., Nichols, W.W., et al. 1996. Revalidation of the in vitro alkaline elution/rat hepatocyte assay for DNA damage: improved criteria for assessment of cytotoxicity and genotoxicity and results for 81 compouns. Mutat. Res. 368: 59-101.
20. Waters, M.D., Stack, H.F., and Jackson, M.A. 1999. Genetic toxicology data in the evaluation of potential human environmental carcinogens. Mutat. Res. 437: 21-49.
21. Woźniak, K., and Blasiak, J. 2003. In vitro genotoxicity of lead acetate: induction of single and double DNA strand breaks and DNA-protein cross-links. Mutat. Res. 535: 127-139.
22. Zyner, E., Graczyk, J., and Ochocki, J. 1999. Pt(II) and Pd(II) complexes of 3-aminoflavone: In vitro and in vivo evaluation. Pharmazie, 54: 945-46.